D. E. Shaw & Co., Inc. - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 221 filers reported holding TRANSMEDICS GROUP INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2023$27,039,461
-19.2%
321,975
-27.2%
0.03%
-22.2%
Q1 2023$33,470,691
+44.7%
441,974
+18.0%
0.04%
+38.5%
Q4 2022$23,124,385
+614.6%
374,666
+383.3%
0.03%
+550.0%
Q3 2022$3,236,00077,5260.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q1 2023
NameSharesValueWeighting ↓
Divisadero Street Capital Management, LP 325,000$27,293,5007.89%
Ophir Asset Management Pty Ltd 418,366$35,134,3777.32%
Sandhill Capital Partners LLC 812,844$68,262,6676.22%
Kent Lake Capital LLC 119,129$10,004,4534.60%
Eagle Health Investments LP 232,032$19,486,0473.64%
NEXT CENTURY GROWTH INVESTORS LLC 442,942$37,198,2693.58%
Bullseye Asset Management LLC 83,012$6,9713.50%
First Light Asset Management, LLC 377,464$31,699,4272.48%
Nicholas Investment Partners, LP 367,631$30,873,6512.11%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 671,716$56,410,7102.09%
View complete list of TRANSMEDICS GROUP INC shareholders